GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » CAS Medical Systems Inc (NAS:CASM) » Definitions » 14-Day RSI

CAS Medical Systems (CAS Medical Systems) 14-Day RSI : N/A (As of May. 05, 2024)


View and export this data going back to 1995. Start your Free Trial

What is CAS Medical Systems 14-Day RSI?

The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100. Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30.

As of today (2024-05-05), CAS Medical Systems's 14-Day RSI is N/A.

The industry rank for CAS Medical Systems's 14-Day RSI or its related term are showing as below:

CASM's 14-Day RSI is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 49
* Ranked among companies with meaningful 14-Day RSI only.

Competitive Comparison of CAS Medical Systems's 14-Day RSI

For the Medical Instruments & Supplies subindustry, CAS Medical Systems's 14-Day RSI, along with its competitors' market caps and 14-Day RSI data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


CAS Medical Systems's 14-Day RSI Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, CAS Medical Systems's 14-Day RSI distribution charts can be found below:

* The bar in red indicates where CAS Medical Systems's 14-Day RSI falls into.



CAS Medical Systems  (NAS:CASM) 14-Day RSI Calculation

The formula for calculating RSI is:

RSI=100[ 100 / ( 1 + Average Gain / Average Loss )]

* Note that the formula uses a positive value for the average loss.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


CAS Medical Systems  (NAS:CASM) 14-Day RSI Explanation

The Relative Strength Index (RSI), developed by J. Welles Wilder in his book “New Concepts in Technical Trading Systems.”, is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100.

Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A RSI surpasses the 30 level indicates a bullish sign, when it slides below 70 level, it’s a bearish sign. This level can be adjusted depending on the security’s pattern and the market’s underlying trend. In an uptrend or bullish market, the RSI might range within a higher interval, investors could set the support level higher. If a downtrend or bearish market occurs, investors may need to lower the resistance level.

RSI can also be used in trading techniques to indicate the trading signal, such as Divergences and Swing Rejections.


CAS Medical Systems 14-Day RSI Related Terms

Thank you for viewing the detailed overview of CAS Medical Systems's 14-Day RSI provided by GuruFocus.com. Please click on the following links to see related term pages.


CAS Medical Systems (CAS Medical Systems) Business Description

Traded in Other Exchanges
N/A
Address
44 East Industrial Road, Branford, CT, USA, 06405
CAS Medical Systems Inc is a medical technology company that develops, manufactures, and markets non-invasive patient monitoring products. The company's products are the FORE-SIGHT and FORE-SIGHT ELITE brand tissue oximeters and sensors. .
Executives
Alan Milinazzo director C/O ORTHOFIX INC, 10115 KINCEY AVENUE STE 250, HUNTERSVILLE NC 28078
Thomas M Patton director, officer: President and CEO C/O OSTEOTCH INC., 51 JAMES WAY, EATONTOWN NJ 07724
Kenneth R Weisshaar director 875 PARK AVE APT 2D, NEW YORK NY 10021
James E Thomas director, 10 percent owner WOODS END ROAD, NEW CANAAN CT 06840
Thomas, Mcnerney & Partners Ii L.p. 10 percent owner 45 SOUTH 7TH STREET, SUITE 3060, Minneapolis MN 55402
Tmp Associates Ii Lp 10 percent owner 45 SOUTH SEVENTH STREET, SUITE 3060, MINNEAPOLIS MN 55402
Tmp Nominee Ii, Llc 10 percent owner 45 SOUTH SEVENTH STREET, SUITE 3060, MINNEAPOLIS MN 55402
Thomas, Mcnerney & Partners Ii, Llc 10 percent owner 45 SOUTH SEVENTH STREET, SUITE 3060, MINNEAPOLIS MN 55402
Acuta Capital Fund, Lp 10 percent owner 1301 SHOREWAY ROAD, SUITE 350, BELMONT CA 94002
James E Flynn 10 percent owner, other: Possible Member of 10% Group 780 THIRD AVENUE, 37TH FLOOR, NEW YORK NY 10017
Deerfield Management Company, L.p. (series C) 10 percent owner, other: Possible Member of 10% Group 345 PARK AVENUE SOUTH, 12TH FLOOR, NEW YORK NY 10010
Deerfield Mgmt L.p. 10 percent owner, other: Possible Member of 10% Group 780 THIRD AVENUE, 37TH FLOOR, NEW YORK NY 10017
Deerfield Special Situations Fund, L.p. 10 percent owner, other: Possible Member of 10% Group 780 3RD AVENUE, 37TH FLOOR, NEW YORK NY 10017
Deerfield Special Situations International Master Fund, L.p. 10 percent owner, other: Possible Member of 10% Group 780 THIRD AVENUE, 37TH FLOOR, NEW YORK NY 10017
Lawrence Burstein director C/O UNITY VENTURE CAPITAL ASSOCIATES LTD, 245 FIFTH AVENUE, SUITE 1500, NEW YORK NY 10016